AXSM Stock: Price, Earnings History and SEC Filings
Axsome Therapeutics, Inc. (AXSM) last traded at $144.43, up 0.68% on the latest session and down 21.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.99 against an analyst estimate of $-0.99, a beat of 0.0%.
$144.43 +0.68%
1 month-21.67%
52-week high$260.19
52-week low$123.50
Volume2.17M
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AXSM earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 10, 2026 | $-0.99 | $-0.99 | +0.00% |
| Mar 2026 | May 4, 2026 | $-1.26 | $-0.85 | -48.24% |
| Dec 2025 | Feb 23, 2026 | $-0.71 | $-0.70 | -1.43% |
| Sep 2025 | Nov 3, 2025 | $-0.94 | $-0.82 | -14.63% |
AXSM beat the analyst EPS estimate in 0 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for AXSM
SEC filing data is not available right now. You can search for AXSM on SEC EDGAR.
AXSM news
- Could Axsome Therapeutics Turn $5,000 Into $50,000 by 2035?Oct 29, 2026 · fool.com
- Axsome Therapeutics vs. Moderna: Consistent Revenue Growth or Sharp VolatilityOct 28, 2026 · fool.com
- Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseOct 27, 2026 · finance.yahoo.com
- Will Axsome Therapeutics (AXSM) Report Negative Earnings Next Week? What You Should KnowOct 26, 2026 · finance.yahoo.com
- 2 Growth Stocks to Hold for the Next Decade (Hint: These Aren’t AI Stocks)Oct 23, 2026 · fool.com
- Will Auvelity Continue to Aid Axsome's Top-Line Growth in Q3?Oct 21, 2026 · finance.yahoo.com
About Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. (AXSM) is a US-listed public company on Nasdaq.